S
DNA icon

SignatureFD’s Ginkgo Bioworks DNA Stock Holding History

SignatureFD’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.53K Sell
249
-303
-55% -$2.52K ﹤0.01% 3126
2025
Q4 		$4.59K Sell
552
-16
-3% -$172 ﹤0.01% 2721
2025
Q3 		$8.28K Sell
568
-58
-9% -$694 ﹤0.01% 2481
2025
Q2 		$7.04K Buy
626
+247
+65% +$1.91K ﹤0.01% 2473
2025
Q1 		$2.16K Buy
+379
New +$3.86K ﹤0.01% 2852
2024
Q2 		– Sell
-53
Closed -$2.44K – 3154
2024
Q1 		$2.44K Sell
53
-23
-30% -$1.19K ﹤0.01% 2750
2023
Q4 		$5.1K Sell
76
-98
-56% -$6K ﹤0.01% 2487
2023
Q3 		$12.6K Buy
174
+20
+13% +$1.6K ﹤0.01% 2083
2023
Q2 		$11.5K Buy
154
+126
+450% +$7.46K ﹤0.01% 2178
2023
Q1 		$1.48K Sell
28
-53
-65% -$3.36K ﹤0.01% 2890
2022
Q4 		$5.49K Buy
81
+72
+800% +$6.62K ﹤0.01% 2431
2022
Q3 		$1K Buy
+9
New +$1.07K ﹤0.01% 2943

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SignatureFD's DNA Position: Q1 2026 in Review

SignatureFD reduced its Ginkgo Bioworks (DNA) stake by 55% in Q1 2026, selling an estimated $2.52K and leaving 249 shares worth $1.53K. The position accounts for ﹤0.01% of the portfolio, ranked #3126.

SignatureFD first reported a position in DNA in Q3 2022 and has held it in 12 quarters since. The position peaked at $12.6K in Q3 2023. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • SignatureFD held 249 shares of Ginkgo Bioworks worth $1.53K as of Q1 2026.
  • SignatureFD sold 303 Ginkgo Bioworks shares in Q1 2026, an estimated $2.52K.
  • Ginkgo Bioworks made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #3126 holding.
  • SignatureFD first reported a position in Ginkgo Bioworks in Q3 2022 and has held it in 12 quarters since.
  • SignatureFD's Ginkgo Bioworks position peaked at $12.6K in Q3 2023.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.